Gilead Sciences

News

US advisors add steroids to COVID-19 drug recommendations

The Infectious Diseases Society of America (IDSA) says generic steroids should be used to treat patients hospitalised with COVID-19.

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

After Celgene deal, BMS shoots up pharma market cap rankings

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalDat

News

Patient on hospital bed with saline solution tube

Gilead will test remdesivir in children with COVID-19

Gilead Sciences has said it will start trials soon of its antiviral drug remdesivir in children – from newborns to adolescents – who have moderate-to-severe COVID-19.

News

Gilead files remdesivir for EU approval, with a verdict poss...

The EMA has said it will fast-track the review of Gilead Sciences’ remdesivir as a treatment for COVID-19, after the US biopharma submitted its marketing application for the dr

News

Close-up image of a firm handshake between two colleagues

AstraZeneca ‘probably couldn’t run Gilead any better:’ analy...

AstraZeneca and Gilead are both staying tight-lipped over rumoured merger talks, but the consensus among analysts seems to be that there would anyway be little value in such a

News